HAR1A and neoplasm: LINC00900, MIR210HG, MIR22HG, PVT1, and SNHG18 expression increased, whereas HAR1A, LINC00641, SLC25A21-AS1, and SNAI3-AS1 expression decreased with tumor grade (Figure 3a, c).